209 related articles for article (PubMed ID: 36586393)
1. Phosphatidylserine-mediated oral tolerance.
Nguyen NH; Chak V; Keller K; Wu H; Balu-Iyer SV
Cell Immunol; 2023 Feb; 384():104660. PubMed ID: 36586393
[TBL] [Abstract][Full Text] [Related]
2. Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.
Glassman FY; Dingman R; Yau HC; Balu-Iyer SV
Immunol Invest; 2020 Oct; 49(7):858-874. PubMed ID: 32204629
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry.
Rodriguez-Fernandez S; Pujol-Autonell I; Brianso F; Perna-Barrull D; Cano-Sarabia M; Garcia-Jimeno S; Villalba A; Sanchez A; Aguilera E; Vazquez F; Verdaguer J; Maspoch D; Vives-Pi M
Front Immunol; 2018; 9():253. PubMed ID: 29491866
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.
Glassman FY; Balu-Iyer SV
Int J Pharm; 2018 Sep; 548(1):642-648. PubMed ID: 29981412
[TBL] [Abstract][Full Text] [Related]
5. Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine.
Nguyen NH; Chen M; Chak V; Balu-Iyer SV
J Pharm Sci; 2022 Jul; 111(7):2072-2082. PubMed ID: 35108564
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine Converts Immunogenic Recombinant Human Acid Alpha-Glucosidase to a Tolerogenic Form in a Mouse Model of Pompe Disease.
Schneider JL; Balu-Iyer SV
J Pharm Sci; 2016 Oct; 105(10):3097-3104. PubMed ID: 27488899
[TBL] [Abstract][Full Text] [Related]
7. Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
Pujol-Autonell I; Serracant-Prat A; Cano-Sarabia M; Ampudia RM; Rodriguez-Fernandez S; Sanchez A; Izquierdo C; Stratmann T; Puig-Domingo M; Maspoch D; Verdaguer J; Vives-Pi M
PLoS One; 2015; 10(6):e0127057. PubMed ID: 26039878
[TBL] [Abstract][Full Text] [Related]
8. Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice.
Gaitonde P; Ramakrishnan R; Chin J; Kelleher RJ; Bankert RB; Balu-Iyer SV
J Biol Chem; 2013 Jun; 288(24):17051-6. PubMed ID: 23649621
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.
Kishimoto TK; Maldonado RA
Front Immunol; 2018; 9():230. PubMed ID: 29515571
[TBL] [Abstract][Full Text] [Related]
10. Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Garcia-Loza I; Perna-Barrull D; Aguilera E; Almenara-Fuentes L; Gomez-Muñoz L; Greco D; Vila M; Salvado M; Mancera-Arteu M; Olszowy MW; Petriz J; Dalmases M; Rodriguez-Vidal S; Barneda-Zahonero B; Vives-Pi M
J Autoimmun; 2024 May; 145():103196. PubMed ID: 38458075
[TBL] [Abstract][Full Text] [Related]
11. The Tim gene family in efferocytosis.
Kim D; Lee SA; Moon H; Kim K; Park D
Genes Genomics; 2020 Sep; 42(9):979-986. PubMed ID: 32648232
[TBL] [Abstract][Full Text] [Related]
12. Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.
Ramakrishnan R; Balu-Iyer SV
J Pharm Sci; 2016 Oct; 105(10):3039-3045. PubMed ID: 27431011
[TBL] [Abstract][Full Text] [Related]
13. Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapy.
Zhang J; Dai Z; Yan C; Wang D; Tang D
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3639-3651. PubMed ID: 34499223
[TBL] [Abstract][Full Text] [Related]
14. TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy.
Dayoub AS; Brekken RA
Cell Commun Signal; 2020 Feb; 18(1):29. PubMed ID: 32087708
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.
Glassman FY; Schneider JL; Ramakrishnan R; Dingman RK; Ramanathan M; Bankert RB; Balu-Iyer SV
J Pharm Sci; 2018 Aug; 107(8):2048-2054. PubMed ID: 29649469
[TBL] [Abstract][Full Text] [Related]
16. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.
Freeman GJ; Casasnovas JM; Umetsu DT; DeKruyff RH
Immunol Rev; 2010 May; 235(1):172-89. PubMed ID: 20536563
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine promotes immunotherapy for airway allergy.
Xue J; Suo L; An Y; Wang X; Zhang S; Liu H; Wu Y; Sun X; Zhao C; Yang P
Immunol Lett; 2023 Dec; 264():46-55. PubMed ID: 38008186
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism for differential recognition of membrane phosphatidylserine by the immune regulatory receptor Tim4.
Tietjen GT; Gong Z; Chen CH; Vargas E; Crooks JE; Cao KD; Heffern CT; Henderson JM; Meron M; Lin B; Roux B; Schlossman ML; Steck TL; Lee KY; Adams EJ
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1463-72. PubMed ID: 24706780
[TBL] [Abstract][Full Text] [Related]
19. Surface code--biophysical signals for apoptotic cell clearance.
Biermann M; Maueröder C; Brauner JM; Chaurio R; Janko C; Herrmann M; Muñoz LE
Phys Biol; 2013 Dec; 10(6):065007. PubMed ID: 24305041
[TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.
Villalba A; Rodriguez-Fernandez S; Ampudia RM; Cano-Sarabia M; Perna-Barrull D; Bertran-Cobo C; Ehrenberg C; Maspoch D; Vives-Pi M
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):77-83. PubMed ID: 31852325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
